Lv31
350 积分 2024-04-17 加入
Enhancing the potency of anti-P32-active targeted PEGylated liposomal doxorubicin using various spacers: in silico, in vitro and in vivo studies
2小时前
待确认
Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years
2小时前
已完结
Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies
22天前
已完结
In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors
1个月前
已完结
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs
1个月前
已完结
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
1个月前
已完结
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
1个月前
已完结
Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis
1个月前
已完结
Controlling the biodistribution and clearance of nanomedicines
4个月前
已完结
New Perspectives in Cell Adhesion: RGD and Integrins
4个月前
已完结
皖公网安备34019202002308
